Orchard Therapeutics plc - American Depositary Shares (ORTX) earnings
Quarterly and annual ORTX reports and results, each read against the price at its own news timestamp. Back to the ORTX overview →
2 measured ORTX earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Orchard Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +0.13% | +0.06% | |
| Orchard Therapeutics Reports Third Quarter 2023 Financial Results and Highlights Recent Business Accomplishments | Press release | +0.13% | +0.06% |
Keep exploring
More ORTX: analyst actions → · SEC filings → · ORTX overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| TRACON PHARMS INC (TCON) | 81 | -0.63% | 16% |
| Homology Medicines, Inc. (FIXX) | 80 | -0.34% | 33% |
| Elite Pharmaceuticals, Inc. (ELTP) | 79 | -0.11% | 42% |
| Genetic Technologies Ltd - American Depositary Shares (GENE) | 79 | -0.05% | 33% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.